Laurel Lee
Laurel Lee (R-FL) sold $100K-$250K of $HURA (TuHURA Biosciences, Inc. - Common Stock (HURA)) on Oct 18, 2024, part of 4 transactions in this filing (2 buys, 1 sells).
HillSignal flagged 2 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 2
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
2 flagsRep. Lee bought $15K-$50K in Pfizer (PFE) on Oct 21, 2024 — 108 days before HR1062 (Growing and Preserving Innovation in America Act of 2025) was introduced, a bill that locks in higher tax deductions for US multinationals and could benefit pharmaceutical companies with foreign IP.
Rep. Lee bought $15K-$50K in Apple (AAPL) on Oct 7, 2024 — 122 days before HR1062 was introduced, a bill that permanently extends tax benefits for US multinationals like Apple that hold intellectual property abroad.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $AAPL | Apple Inc. - Common Stock (AAPL) | $15K-$50K | $221.69 | $288.42 | +30.1% | Oct 7, 2024 |
| BUY | $PFE | Pfizer, Inc. Common Stock | $15K-$50K | $28.93 | $24.13 | -16.6% | Oct 21, 2024 |
| EXCHANGE | $HURA | TuHURA Biosciences, Inc. - Common Stock (HURA) | $100K-$250K | $6.30 | $2.30 | -63.5% | Oct 18, 2024 |
| SELL | $GEV | GE Vernova Inc. Common Stock | $15K-$50K | $341.18 | $1,160.38 | +240.1% | Nov 8, 2024 |
Connected Legislative Activity
2 signalsThese bills and contracts share tickers or sectors with this filing's trades.
No Tax Breaks for Outsourcing Act
The No Tax Breaks for Outsourcing Act (S409) would eliminate tax deferral on foreign profits for U.S. multinationals, increasing effective tax rates by 5-8 percentage points. The bill is in early stages (referred to Senate Finance Committee, 19 cosponsors) and poses a 4-8% annual net income headwind for high international-exposure companies. Despite 8-30% rallies in the last 30 days across MSFT, AAPL, GOOGL, KO, PG, XOM, and CVX, this legislative risk is not currently priced into valuations.
Growing and Preserving Innovation in America Act of 2025
HR1062 permanently locks in higher FDII and GILTI deductions for US multinationals, preventing a ~3.3 ppt effective tax rate increase on foreign IP income scheduled for 2026. This directly boosts after-tax net income for companies with large international revenue streams, including MSFT, AAPL, GOOGL, AMZN, NVDA, JNJ, PFE, KO, and PG. The bill is in early committee stage — structural impact is contingent on passage through the 119th Congress.
Other Filings by Laurel Lee
Free — no credit card
Get the next Lee trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.